세계의 체외진단(IVD) 품질관리 시장 : 전략과 동향, 어세이 유형별, 장소별, 제품별, 제조업체별, 국가별 예측 - 경영진 컨설턴트 가이드 포함(2025-2029년)

In Vitro Diagnostic Quality Control Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country. Situation Analysis with Executive & Consultant Guides. 2025 to 2029.

US $ 6,995 ￦ 10,381,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495 ￦ 15,576,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 20,771,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

IVD 품질 관리 업계는 전염병의 도전에 맞서고 있습니다. 불황과 무관한 이 업계는 지금 새로운 기회가 넘쳐나고 있습니다. 새로운 기술과 새로운 분야가 급격한 성장의 원동력이 되고 있습니다. 이 종합적인 보고서를 통해 기회와 위협을 이해할 수 있습니다.

임상검사는 생명공학, 특히 유전체학의 폭발적인 발전의 직접적인 수혜를 받을 수 있는 위치에 있습니다. 다양한 역동적 인 동향은 시장의 성장과 기업의 평가를 높이고 있습니다. 품질 관리 업계는 이익을 얻을 수 있는 위치에 있습니다.

이 보고서는 분석가 및 기획자들이 활용할 수 있는 데이터를 제공합니다. 임상 검사 동향과 IVD의 역할에 대한 자세한 정보를 포함한 100페이지 분량의 정보를 다루고 있으며, 새로운 검사법과 기술에 대한 수요를 예측했습니다.

본 보고서에는 15개 국가 및 4개 지역별 상세 분석이 포함되어 있습니다. 본 보고서를 구매하신 분들은 전 세계 모든 국가별 상세 내역을 보실 수 있습니다.

최신 데이터를 통해 투자 판단과 밸류에이션에 도움이 될 수 있습니다.

세계의 체외진단 품질 관리 시장에 대해 조사했으며, 시장 개요와 함께 분석 유형별/지역별/제품별/제조업체별/국가별 동향, 시장 진출기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 시장 가이드

제2장 서론과 시장의 정의

• IVD 품질 관리란 무엇인가?
• 기회 정의
• 조사 방법
• 시점 : 헬스케어와 IVD 업계

제3장 역동적인 시장 개요

• 시장 참여 조직
  • 학술연구기관
  • 진단 시험 개발자
  • 계측 기기 공급업체
  • 약품 및 시약 제조업체
  • 병리 공급업체
  • 독립계 임상 실험실
  • 공공 국립 및 지역 연구소
  • 병원 검사실
  • 임상 실험실
  • 감사기관
  • 인증기관
• 세분화 - 다양한 접근
• 임상 검사 업계 구조
• 나라와 지역 다양성

제4장 변화하는 시장 성장을 촉진하는 동향

• 많은 측면에서 성장 촉진요인
• 시장 축소 요인
• 자동화 및 연구실 동향

제5장 IVD 품질 관리의 최근 동향

제6장 주요 기업 개요

• Abbott Laboratories
• Alpha-Tec Systems
• Beckman Coulter Diagnostics(Danaher)
• Becton, Dickinson and Company
• BioFire Diagnostics(bioMerieux)
• bioMerieux Diagnostics
• Bio-Rad Laboratories, Inc.
• Bio-Techne
• Danaher Corporation
• Diasorin S.p.A.
• Fortress Diagnostics
• Grifols
• Helena Laboratories
• Hologic
• LGC Standards
• Maine Molecular Quality Controls
• Microbiologics
• Microbix Systems
• Novacyt
• QuidelOrtho
• Randox Toxicology
• Seegene
• SERO
• Siemens Healthineers
• Streck
• Sun Diagnostics
• Sysmex
• Thermo Fisher Scientific
• ZeptoMetrix

제7장 세계의 IVD 품질 관리 시장

• 국가별 세계 시장 개요
• 어세이 유형별 세계 시장 - 개요
• 장소별 세계 시장 - 개요
• 제품별 세계 시장 - 개요
• 제조업체별 세계 시장 - 개요

제8장 세계의 IVD 품질 관리 시장 - 어세이 유형별

• 화학
• 미생물학
• 혈액학
• 해부병리학
• 분자진단
• 난해 분야

제9장 세계의 IVD 품질 관리 시장 - 장소별

• 병원
• 외래 검사실
• 연구실
• 병원 검사실
• 기타 연구실

제10장 세계의 IVD 품질 관리 시장 - 제품별

• 전혈
• 혈장
• 소변
• 제어 재료 기타

제11장 세계의 IVD 품질 관리 시장 - 제조업체별

• OEM
• 써드파티 제네릭 제조업체
• 써드파티 기기 제조업체
• 커스텀 기타

제12장 부록

LSH

영문 목차

영문목차

The IVD Quality Control industry rose to the challenge of the pandemic. Now new opportunities abound in this established industry that is immune from recession. New technology and new segments are driving runaway growth. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. The Quality Control industry stands to gain.

The report provides data that analysts and planners can use. Hundreds of pages of information including detailed information on clinical laboratory trends and the role of IVD. Forecast demand for new testing regimes or technologies. Make research investment decisions.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

• 1.1. Strategic Situation Analysis
• 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors
• 1.4. Impact of Artificial Intelligence

2. Introduction and Market Definition

• 2.1. What is IVD Quality Control?
• 2.2. Defining the Opportunity
  • 2.2.1. Revenue Market Size
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics

3. Overview of a Dynamic Market

• 3.1. Players in a Dynamic Market
  • 3.1.1. Academic Research Lab
  • 3.1.2. Diagnostic Test Developer
  • 3.1.3. Instrumentation Supplier
  • 3.1.4. Chemical/Reagent Supplier
  • 3.1.5. Pathology Supplier
  • 3.1.6. Independent Clinical Laboratory
  • 3.1.7. Public National/regional Laboratory
  • 3.1.8. Hospital Laboratory
  • 3.1.9. Physicians Office Lab (POLS)
  • 3.1.10. Audit Body
  • 3.1.11. Certification Body
• 3.2. Segmentation - Different Approaches
  • 3.2.1. Traditional Market Segmentation
  • 3.2.2. Laboratory Focus and Segmentation
• 3.3. Structure of Clinical Testing Industry
  • 3.3.1. The Hospital Lab - Share of the Pie
  • 3.3.2. Key Role for Economies of Scale
  • 3.3.3. Physician Office Lab's are Still Here
  • 3.3.4. Physician's and POCT - Reviving Patient Service in China
• 3.4. National and Regional Diversity

4. Trends Driving a Changing Market

• 4.1. Growth Is Pushed from Many Sides
  • 4.1.1. Demographic Impacts on Consumption
  • 4.1.2. Alternative Suppliers
  • 4.1.3. Impact of POC
  • 4.1.4. Impact of Accreditation
  • 4.1.5. Genetic and Molecular Issues
• 4.2. Factors at Work to Shrink the Market
  • 4.2.1. Where are Costs Going?
  • 4.2.2. Management Practices
  • 4.2.3. Cannabilization
  • 4.2.4. Point of Care
• 4.3. Automation and Laboratory Trends
  • 4.3.1. Traditional Automation and Centralization
  • 4.3.2. The New Automation, Decentralization and Point Of Care
  • 4.3.3. Instruments Key to Market Share
  • 4.3.4. Bioinformatics Plays a Role
  • 4.3.5. PCR Takes Command
  • 4.3.6. Next Generation Sequencing Fuels a Revolution
  • 4.3.7. NGS Impact on Pricing
  • 4.3.8. Whole Genome Sequencing, A Brave New World
  • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
  • 4.3.10. Shifting Role of Diagnostics

5. IVD Quality Control Recent Developments

• 5.1. Recent Developments - Importance and How to Use This Section
  • 5.1.1. Importance of These Developments
  • 5.1.2. How to Use This Section
• 5.2. Lab Missteps Lead to Dismissed Charges
• 5.3. bioMerieux Launches Diagnostic Solution for Food Industries
• 5.4. Automation from Siemens Tackles Lab Challenges
• 5.5. New FDA Quality Regulations Spark Questions
• 5.6. Waters MassTrak Steroid Serum (IVD) Sets
• 5.7. Cancer Test Harmonization Efforts Progress
• 5.8. Bio-Techne Expanding With Ella Immunoassay Instrument
• 5.9. ZeptoMetrix QC Products Receive IVDR Certification
• 5.10. Coverage Criteria for Cancer Genetic Tests Creates Alarm
• 5.11. IVDR Rollout Brings QC Hurdles for Clinical Labs
• 5.12. LGC Clinical Diagnostics Acquires QC Product Maker Kova International
• 5.13. FDA Probing Lab Test Quality in Cancer Care
• 5.14. Sensible Diagnostics to Launch 10-Minute POC PCR System
• 5.15. Streck Gets FDA Clearance for BioFire Sepsis Panel Control Material

6. Profiles of Key Companies

• 6.1. Abbott Laboratories
• 6.2. Alpha-Tec Systems
• 6.3. Beckman Coulter Diagnostics (Danaher)
• 6.4. Becton, Dickinson and Company
• 6.5. BioFire Diagnostics (bioMerieux)
• 6.6. bioMerieux Diagnostics
• 6.7. Bio-Rad Laboratories, Inc.
• 6.8. Bio-Techne
• 6.9. Danaher Corporation
• 6.10. Diasorin S.p.A.
• 6.11. Fortress Diagnostics
• 6.12. Grifols
• 6.13. Helena Laboratories
• 6.14. Hologic
• 6.15. LGC Standards
• 6.16. Maine Molecular Quality Controls
• 6.17. Microbiologics
• 6.18. Microbix Systems
• 6.19. Novacyt
• 6.20. QuidelOrtho
• 6.21. Randox Toxicology
• 6.22. Seegene
• 6.23. SERO
• 6.24. Siemens Healthineers
• 6.25. Streck
• 6.26. Sun Diagnostics
• 6.27. Sysmex
• 6.28. Thermo Fisher Scientific
• 6.29. ZeptoMetrix

7. The Global Market for IVD Quality Control

• 7.1. Global Market Overview by Country
  • 7.1.1. Table - Global Market by Country
  • 7.1.2. Chart - Global Market by Country
• 7.2. Global Market by Assay Type - Overview
  • 7.2.1. Table - Global Market by Assay Type
  • 7.2.2. Chart - Global Market by Assay Type - Base/Final Year Comparison
  • 7.2.3. Chart - Global Market by Assay Type - Base Year
  • 7.2.4. Chart - Global Market by Assay Type - End Year
  • 7.2.5. Chart - Global Market by Assay Type - Share by Year
  • 7.2.6. Chart - Global Market by Assay Type - Segments Growth
• 7.3. Global Market by Place - Overview
  • 7.3.1. Table - Global Market by Place
  • 7.3.2. Chart - Global Market by Place - Base/Final Year Comparison
  • 7.3.3. Chart - Global Market by Place - Base Year
  • 7.3.4. Chart - Global Market by Place - End Year
  • 7.3.5. Chart - Global Market by Place - Share by Year
  • 7.3.6. Chart - Global Market by Place - Segments Growth
• 7.4. Global Market by Product - Overview
  • 7.4.1. Table - Global Market by Product
  • 7.4.2. Chart - Global Market by Product - Base/Final Year Comparison
  • 7.4.3. Chart - Global Market by Product - Base Year
  • 7.4.4. Chart - Global Market by Product - End Year
  • 7.4.5. Chart - Global Market by Product - Share by Year
  • 7.4.6. Chart - Global Market by Product - Segments Growth
• 7.5. Global Market by Manufacturer- Overview
  • 7.5.1. Table - Global Market by Manufacturer
  • 7.5.2. Chart - Global Market by Manufacturer - Base/Final Year Comparison
  • 7.5.3. Chart - Global Market by Manufacturer - Base Year
  • 7.5.4. Chart - Global Market by Manufacturer - End Year
  • 7.5.5. Chart - Global Market by Manufacturer - Share by Year
  • 7.5.6. Chart - Global Market by Manufacturer - Segments Growth

8. Global IVD Quality Control Markets - By Assay Type

• 8.1. Chemistry
  • 8.1.1. Table Chemistry - by Country
  • 8.1.2. Chart - Chemistry Growth
• 8.2. Microbiology
  • 8.2.1. Table Microbiology - by Country
  • 8.2.2. Chart - Microbiology Growth
• 8.3. Hematology
  • 8.3.1. Table Hematology - by Country
  • 8.3.2. Chart - Hematology Growth
• 8.4. Anatomic Pathology
  • 8.4.1. Table Anatomic Pathology - by Country
  • 8.4.2. Chart - Anatomic Pathology Growth
• 8.5. Molecular Diagnostics
  • 8.5.1. Table Molecular Diagnostics - by Country
  • 8.5.2. Chart - Molecular Diagnostics Growth
• 8.6. Esoteric
  • 8.6.1. Table Esoteric - by Country
  • 8.6.2. Chart - Esoteric Growth

9. Global IVD Quality Control Markets - By Place

• 9.1. Hospital
  • 9.1.1. Table Hospital - by Country
  • 9.1.2. Chart - Hospital Growth
• 9.2. Outpatient Laboratory
  • 9.2.1. Table Outpatient Laboratory - by Country
  • 9.2.2. Chart - Outpatient Laboratory Growth
• 9.3. Research Laboratory
  • 9.3.1. Table Research Laboratory - by Country
  • 9.3.2. Chart - Research Laboratory Growth
• 9.4. Physicians Office Laboratory
  • 9.4.1. Table Physicians Office Laboratory - by Country
  • 9.4.2. Chart - Physicians Office Laboratory Growth
• 9.5. Other Laboratory
  • 9.5.1. Table Other Laboratory - by Country
  • 9.5.2. Chart - Other Laboratory Growth

10. Global IVD Quality Control Markets - By Product

• 10.1. Whole Blood
  • 10.1.1. Table Whole Blood- by Country
  • 10.1.2. Chart - Whole Blood Growth
• 10.2. Plasma
  • 10.2.1. Table Plasma - by Country
  • 10.2.2. Chart - Plasma Growth
• 10.3. Urine
  • 10.3.1. Table Urine - by Country
  • 10.3.2. Chart -Urine Growth
• 10.4. Control Material Other
  • 10.4.1. Table Control Material Other - by Country
  • 10.4.2. Chart - Control Material Other Growth

11. Global IVD Quality Control Markets - By Manufacturer

• 11.1. Original Equipment Manufacturer
  • 11.1.1. Table Original Equipment Manufacturer - by Country
  • 11.1.2. Chart - Original Equipment Manufacturer Growth
• 11.2. Third Party Generic
  • 11.2.1. Table Third Party Generic - by Country
  • 11.2.2. Chart - Third Party Generic Growth
• 11.3. Third Party Instrument Specific
  • 11.3.1. Table Third Party Instrument Specific - by Country
  • 11.3.2. Chart - Third Party Instrument Specific Growth
• 11.4. Custom Other
  • 11.4.1. Table Custom Other - by Country
  • 11.4.2. Chart - Custom Other Growth

12. Appendices

• 12.1. Growth of Approved IVD Test Menu
• 12.2. Growth of Approved Average IVD Test Fee
• 12.3. The Most Used IVD Assays
• 12.4. The Highest Grossing Assays
• 12.5. Laboratory Fees Schedule

관련자료